Lilly launches lower-price weight loss drug without injector pen - CNN
Aug 27, 2024 · Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will …
Zepbound price cut: Eli Lilly lowers cost of weight loss drug - NBC News
Aug 27, 2024 · Drugmaker Eli Lilly is significantly lowering the prices of the two lowest doses of its blockbuster weight loss drug Zepbound.
Eli Lilly to sell Zepbound directly to consumers without ... - ABC News
Aug 27, 2024 · Eli Lilly, the maker of Zepbound, announced Tuesday it will begin selling the weight loss drug directly to consumers through the company's direct pharmacy, LillyDirect.
Zepbound: Eli Lilly releases new, cheaper form of weight loss drug
Aug 27, 2024 · Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to reach millions of patients without insurance coverage …
As Zepbound shortage grows, Eli Lilly says no immediate end ... - NBC News
Apr 18, 2024 · Zepbound drugmaker Eli Lilly is working to increase its weight loss drug supply. But some steps to get there, including building a new plant, will take months to execute.
Zepbound: The newest obesity medication explained by an expert - CNN
Nov 14, 2023 · The US Food and Drug Administration approved the medication Zepbound last week to treat chronic obesity. The injectable drug, made by the pharmaceutical company Eli …
Zepbound outperforms Ozempic and Wegovy in head-to-head ... - NBC News
Jul 8, 2024 · Since Zepbound was approved for weight loss in late 2023, it appeared to have an advantage over Wegovy.
Weight loss drug Zepbound is now available, Eli Lilly says
Dec 6, 2023 · Drug manufacturer Eli Lilly announced Tuesday that its flagship weight loss medication, Zepbound, is now available for patient use. Tirzepatide, its active ingredient, had …
FDA approves Zepbound, new Wegovy rival : Shots - Health News : NPR
Nov 8, 2023 · An obesity drug called Zepbound won approval for use in adults from the Food and Drug Administration Wednesday, ushering in a new rival to Novo Nordisk's blockbuster Wegovy.
Eli Lilly expects FDA call on Zepbound for sleep apnea in near term
Jun 21, 2024 · Eli Lilly said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing disorder and expects regulators to …